InvestorsHub Logo
Followers 7
Posts 451
Boards Moderated 0
Alias Born 12/27/2010

Re: None

Wednesday, 08/24/2016 9:25:27 AM

Wednesday, August 24, 2016 9:25:27 AM

Post# of 1439
Receives orphan drub designation for phosphoinositide-3-kinase delta inhibitor. Treatment of chronic lymphocytic leukemia. No announcement yet. Should run when announced. Low float with an analyst target of $30 and a buy rating.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TGTX News